Display options
Cite
Soleimanpour H, Safari S, Rahmani F, et al. The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article. Anesth Pain Med. 2015;5(1):e23409doi: 10.5812/aapm.23409.
Soleimanpour, H., Safari, S., Rahmani, F., Ameli, H., & Alavian, S. M. (2015). The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article. Anesthesiology and pain medicine, 5(1), e23409. https://doi.org/10.5812/aapm.23409
Soleimanpour, Hassan, et al. "The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article." Anesthesiology and pain medicine vol. 5,1 (2015): e23409. doi: https://doi.org/10.5812/aapm.23409
Soleimanpour H, Safari S, Rahmani F, Ameli H, Alavian SM. The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article. Anesth Pain Med. 2015 Jan 07;5(1):e23409. doi: 10.5812/aapm.23409. eCollection 2015 Feb. PMID: 25789242; PMCID: PMC4350156.
Copy Download .nbib Format: NLM
Share it on

Anesth Pain Med. 2015 Jan 07;5(1):e23409. doi: 10.5812/aapm.23409. eCollection 2015 Feb.

The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article.

Anesthesiology and pain medicine

Hassan Soleimanpour, Saeid Safari, Farzad Rahmani, Hoorolnesa Ameli, Seyed Moayed Alavian

Affiliations

  1. Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  2. Department of Anesthesiology, Iran University of Medical Sciences, Tehran, Iran.
  3. Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  4. Students' Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  5. Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 25789242 PMCID: PMC4350156 DOI: 10.5812/aapm.23409

Abstract

CONTEXT: Anesthetic drugs including halogenated anesthetics have been common for many years. Consequent hepatic injury has been reported in the literature. The mechanism of injury is immunoallergic. The first generation drug was halothane; it had the most toxicity when compared to other drugs. The issue becomes more important when the patient has an underlying hepatic dysfunction.

EVIDENCE ACQUISITION: In this paper, reputable internet databases from 1957-2014 were analyzed and 43 original articles, 3 case reports, and 3 books were studied. A search was performed based on the following keywords: inhalational anesthesia, hepatic dysfunction, halogenated anesthetics, general anesthesia in patients with hepatic diseases, and side effects of halogenated anesthetics from reliable databases. Reputable websites like PubMed and Cochrane were used for the searches.

RESULTS: In patients with hepatic dysfunction in addition to hepatic system and dramatic hemostatic dysfunction, dysfunction of cardiovascular, renal, respiratory, gastrointestinal, and central nervous systems may occur. On the other hand, exposure to inhalational halogenated anesthetics may have a negative impact (similar to hepatitis) on all aforementioned systems in addition to direct effects on liver function as well as the effects are more pronounced in halothane.

CONCLUSIONS: Despite the adverse effects of inhalational halogenated anesthetics (especially halothane) on hepatic patients when necessary. The effects on all systems must be considered and the necessary preparations must be provided. These drugs are still used, if necessary, due to the presence of positive effects and advantages mentioned in other studies as well as the adverse effects of other drugs.

Keywords: Halothane; Hepatitis; Inhalational Anesthetics

References

  1. Can J Anaesth. 1998 Aug;45(8):753-6 - PubMed
  2. Hepatology. 2007 Mar;45(3):797-805 - PubMed
  3. Anesth Pain Med. 2014 Jun 18;4(3):e17880 - PubMed
  4. Am J Med. 1958 Mar;24(3):358-67 - PubMed
  5. Anesth Pain Med. 2014 Feb 13;4(1):e16222 - PubMed
  6. N Engl J Med. 2011 Jul 14;365(2):147-56 - PubMed
  7. Anesth Analg. 2007 Jun;104(6):1452-3, table of contents - PubMed
  8. Anesth Pain Med. 2014 Jun 23;4(3):e15363 - PubMed
  9. Hepat Mon. 2014 Aug 16;14(8):e18128 - PubMed
  10. Iran Red Crescent Med J. 2014 Sep 05;16(9):e20153 - PubMed
  11. Hepat Mon. 2014 Jun 07;14(6):e18625 - PubMed
  12. Br J Anaesth. 1957 Oct;29(10):466-72 - PubMed
  13. Anesthesiology. 1970 Aug;33(2):193-213 - PubMed
  14. Hepat Mon. 2014 Apr 07;14(4):e15449 - PubMed
  15. Hepat Mon. 2014 Aug 18;14(8):e19747 - PubMed
  16. Anesthesiology. 2004 Dec;101(6):1313-24 - PubMed
  17. East Mediterr Health J. 2012 Feb;18(2):159-64 - PubMed
  18. Eur J Anaesthesiol. 2013 Oct;30(10):612-7 - PubMed
  19. JAMA. 1999 Nov 3;282(17):1638-45 - PubMed
  20. Hepat Mon. 2011 Jul;11(7):511-2 - PubMed
  21. Crit Care Med. 2004 Apr;32(4 Suppl):S106-15 - PubMed
  22. Hepat Mon. 2014 Jul 01;14(7):e19881 - PubMed
  23. Hepat Mon. 2014 Aug 17;14(8):e20540 - PubMed
  24. Liver Transpl. 2012 Mar;18(3):370-5 - PubMed
  25. Hepat Mon. 2014 Jun 01;14(6):e19880 - PubMed
  26. J Cardiovasc Thorac Res. 2012;4(3):73-6 - PubMed
  27. Indian J Gastroenterol. 2006 Jan-Feb;25(1):41-2 - PubMed
  28. Anesth Analg. 1997 Jan;84(1):160-8 - PubMed
  29. Eur J Anaesthesiol. 1997 Jan;14 (1):7-14 - PubMed
  30. Anesth Pain Med. 2013 Sep;3(2):234-8 - PubMed
  31. Can J Anaesth. 1996 Jul;43(7):741-8 - PubMed
  32. Anesth Pain Med. 2013 Summer;3(1):191-7 - PubMed
  33. BMC Emerg Med. 2011 Jun 16;11:8 - PubMed
  34. Korean J Anesthesiol. 2014 Mar;66(3):199-203 - PubMed
  35. Int Anesthesiol Clin. 2006 Fall;44(4):59-78 - PubMed
  36. Curr Opin Anaesthesiol. 2012 Jun;25(3):340-7 - PubMed
  37. Int J Mol Sci. 2014 Apr 22;15(4):6990-7003 - PubMed
  38. Indian J Anaesth. 2011 May;55(3):290-2 - PubMed
  39. Anesth Pain Med. 2014 Jun 21;4(3):e14903 - PubMed
  40. Liver Transpl Surg. 1999 Nov;5(6):497-501 - PubMed
  41. QJM. 2008 Feb;101(2):71-85 - PubMed
  42. N Engl J Med. 2008 May 29;358(22):2378-87 - PubMed
  43. Hepat Mon. 2013 Aug 25;13(8):e13162 - PubMed

Publication Types